Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Significance of High-Containment Biological Laboratories Performing Work During the COVID-19 Pandemic: Biosafety Level-3 and -4 Labs.
Yeh KB, Tabynov K, Parekh FK, Mombo I, Parker K, Tabynov K, Bradrick SS, Tseng AS, Yang JR, Gardiner L, Olinger G, Setser B. Yeh KB, et al. Among authors: olinger g. Front Bioeng Biotechnol. 2021 Aug 13;9:720315. doi: 10.3389/fbioe.2021.720315. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 34485259 Free PMC article.
Erratum for Herring et al., "Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs".
Herring S, Oda JM, Wagoner J, Kirchmeier D, O'Connor A, Nelson EA, Huang Q, Liang Y, DeWald LE, Johansen LM, Glass PJ, Olinger GG, Ianevski A, Aittokallio T, Paine MF, Fink SL, White JM, Polyak SJ. Herring S, et al. Among authors: olinger gg. Antimicrob Agents Chemother. 2021 May 18;65(6):e00653-21. doi: 10.1128/AAC.00653-21. Print 2021 May 18. Antimicrob Agents Chemother. 2021. PMID: 34006613 Free PMC article. No abstract available.
Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs against Ebola Virus In Vivo.
Finch CL, Dyall J, Xu S, Nelson EA, Postnikova E, Liang JY, Zhou H, DeWald LE, Thomas CJ, Wang A, Xu X, Hughes E, Morris PJ, Mirsalis JC, Nguyen LH, Arolfo MP, Koci B, Holbrook MR, Hensley LE, Jahrling PB, Schmaljohn C, Johansen LM, Olinger GG, Schiffer JT, White JM. Finch CL, et al. Among authors: olinger gg. Microorganisms. 2021 Mar 10;9(3):566. doi: 10.3390/microorganisms9030566. Microorganisms. 2021. PMID: 33801811 Free PMC article.
COVID-19 vaccines: Global challenges and prospects forum recommendations.
Boudjelal M, Almajed F, Salman AM, Alharbi NK, Colangelo M, Michelotti JM, Olinger G, Baker M, Hill AVS, Alaskar A. Boudjelal M, et al. Among authors: olinger g. Int J Infect Dis. 2021 Apr;105:448-451. doi: 10.1016/j.ijid.2021.02.093. Epub 2021 Feb 27. Int J Infect Dis. 2021. PMID: 33652065 Free PMC article.
Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs.
Herring S, Oda JM, Wagoner J, Kirchmeier D, O'Connor A, Nelson EA, Huang Q, Liang Y, DeWald LE, Johansen LM, Glass PJ, Olinger GG, Ianevski A, Aittokallio T, Paine MF, Fink SL, White JM, Polyak SJ. Herring S, et al. Among authors: olinger gg. Antimicrob Agents Chemother. 2021 Mar 18;65(4):e01146-20. doi: 10.1128/AAC.01146-20. Print 2021 Mar 18. Antimicrob Agents Chemother. 2021. PMID: 33468464 Free PMC article.
233 results